openPR Logo
Press release

Investors who lost money with shares of Liquidia Corporation (NASDAQ: LQDA) should contact the Shareholders Foundation in connection with Investigation

09-20-2024 03:12 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation for investors in Liquidia Corporation (NASDAQ: LQDA) shares over potential securities laws violations by Liquidia

An investigation for investors in Liquidia Corporation (NASDAQ: LQDA) shares over potential securities laws violations by Liquidia

An investigation was announced over potential securities laws violations by Liquidia Corporation in connection with certain financial statements.

Investors who purchased shares of Liquidia Corporation (NASDAQ: LQDA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Liquidia Corporation (NASDAQ: LQDA) concerning whether a series of statements by Liquidia Corporation regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Morrisville, NC based Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Liquidia Corporation reported that its annual Total Revenue rose from $15.93 million in 2022 to $17.48 million in 2023, and that its Net Loss increased from $41.01 million in 2022 to $78.5 million in 2023.

On August 19, 2024, Liquidia issued a press release announcing that "the U.S. Food and Drug Administration (FDA) has granted tentative approval of YUTREPIA™ (treprostinil) inhalation powder to treat adults with pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD)" but "must await the expiration of regulatory exclusivity of a competing product before final approval can be granted.

Shares of Liquidia Corporation (NASDAQ: LQDA) declined from $16.99 per share on March 22, 2024, to $8.26 per share on August 19, 2024.

Those who purchased shares of Liquidia Corporation (NASDAQ: LQDA) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investors who lost money with shares of Liquidia Corporation (NASDAQ: LQDA) should contact the Shareholders Foundation in connection with Investigation here

News-ID: 3661673 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Liquidia

Hypertension Pipeline Progresses: 100+ Therapies Pushing Innovation - DelveInsig …
Fueled by relentless research, the Hypertension pipeline is witnessing transformative developments, with key players accelerating breakthroughs in treatment. DelveInsight's "Hypertension Pipeline Insight, 2025" comprehensively analyzes the current clinical landscape and growth prospects in the Hypertension market. The report covers disease insights, treatment guidelines, and a detailed pipeline assessment from preclinical to marketed stages. It includes drug mechanisms, clinical studies, regulatory progress, and key developments such as collaborations, mergers, funding, and designations. For
Global Stencil Lithography Market to Expand with Significant CAGR by 2028 | ASML …
The latest investigation report distributed by MarketsandResearch.biz, the Global Stencil Lithography Market is needed to note huge advancement throughout the fundamental quantity 2022 to 2028. The assessment report offers a market share examination to the extent of mass and volume. Supported the first and in-depth secondary analysis, the study has been developed based on recent trends, rating analysis, potential and historic demand & supply, economic condition, COVID-19 impact, and alternative factors. DOWNLOAD
Stencil Lithography Market to Witness Huge Growth by Key Players: ASML, Liquidia …
The research reports on "Stencil Lithography Market" report gives detailed overview of factors that affect global business scope. Stencil Lithography Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5557548 The
Nanotechnology and Nanomaterials Market 2021 Analysis by Global Manufacturers - …
The "Nanotechnology and Nanomaterials" Market report offers qualitative and quantitative insights and a detailed analysis of market size & growth rate for all possible segments in the market. The Global Nanotechnology and Nanomaterials Industry presents a market overview, product details, classification, and market concentration. The report also provides an in-depth survey of key players in the market which is based on various competitive intelligence parameters like company profiles, product picture
Nanotechnology and Nanomaterials market Market Insights Shared In Detailed Repor …
The global Nanotechnology and Nanomaterials market size was valued at USD 8.7 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 13.5% from 2021 to 2027. The Market Research on the “Nanotechnology and Nanomaterials Market 2021-2027”, now available with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The Nanotechnology and
Investigation announced for Investors in shares of Liquidia Corporation (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Liquidia Corporation . Investors who purchased shares of Liquidia Corporation (NASDAQ: LQDA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Liquidia Corporation directors breached their fiduciary duties and caused damage to the company and its shareholders. Morrisville, NC based